Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 2
  • Print publication year: 2010
  • Online publication date: July 2010

5 - Pathological Gambling: Clinical Aspects

from Section I - Acquisitive Impulses

Related content

Powered by UNSILO

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. Washington, DC: American Psychiatric Association, 1980.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association, 2000.
Baron E, Dickerson M. Alcohol consumption and self-control of gambling behaviour. J Gambl Stud 15:3–15, 1999.
Bechara A, Damasio AR, Damasio H et al. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50:7–15, 1994.
Black DW, Arndt S, Coryell WH et al. Bupropion in the treatment of pathological gambling: A randomized, double-blind, placebo-controlled, flexible-dose study. J Clin Psychopharmacol 27:143–150, 2007.
Black DW, Monahan PO, Temkit M et al. A family study of pathologic gambling. Psychiatry Res 141:295–303, 2006.
Black DW, Moyer T. Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 49:1434–1439, 1998.
Black DW, Moyer T, Schlosser S. Quality of life and family history in pathological gambling. J Nerv Ment Dis 191:124–126, 2003.
Blanco C, Petkova E, Ibáñez A et al. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 14:9–15, 2002.
Bland RC, Newman SC, Orn H et al. Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 38:108–112, 1993.
Blaszczynski A. Overcoming Compulsive Gambling: A Self-Help Guide Using Cognitive Behavioral Techniques. London: Robinson, 1998.
Blaszczynski A, McConaghy N. Anxiety and/or depression in the pathogenesis of addictive gambling. Int J Addict 24:337–350, 1989.
Blaszczynski A, Silove D. Pathological gambling: Forensic issues. Aust NZ J Psychiatry 30:358–369, 1996.
Blaszczynski A, Steel Z. Personality disorders among pathological gamblers. J Gambl Stud 14:51–71, 1998.
Brand M, Kalbe E, Labudda K et al. Decision-making impairments in patients with pathological gambling. Psychiatry Res 30(133): 91–99, 2005.
Cavedini P, Riboldi G, Keller R et al. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry 51:334–341, 2002.
Crisp BR, Thomas SA, Jackson AC et al. Not the same: A comparison of female and male clients seeking treatment from problem gambling counseling services. J Gambl Stud 20:283–299, 2004.
Crockford DN, el-Guebaly N. Psychiatric comorbidity in pathological gambling: A critical review. Can J Psychiatry 43:43–50, 1998.
Crockford DN, Goodyear B, Edwards J et al. Cue-induced brain activity in pathological gamblers. Biol Psychiatry 58:787–795, 2005.
Cummings DL. Frontal-subcortical circuits and human behavior. Arch Neurol 50:873–880, 1993.
Cunningham-Williams RM, Cottler LB, Compton WM 3rd et al. Taking chances: Problem gamblers and mental health disorders – results from the St. Louis Epidemiologic Catchment Area Study. Am J Pub Health 88:1093–1096, 1998.
Custer RL. Profile of the pathological gambler. J Clin Psychiatry 45:35–38, 1984.
Dickerson M, Hinchy J, England SL. Minimal treatments and problem gamblers: A preliminary investigation. J Gambl Stud 6:87–102, 1990.
Echeburúa E, Baez C, Fernández-Montalvo J. Comparative effectiveness of three therapeutic modalities in psychological treatment of pathological gambling: Long term outcome. Behav Cognit Psychother 24:51–72, 1996.
Echeburúa E, Fernández-Montalvo J, Baez C. Predictors of therapeutic failure in slot-machine pathological gamblers following behavioural treatment. Behav Cognit Psychother 29:379–383, 2001.
Eisen SA, Lin N, Lyons MJ et al. Familial influences on gambling behavior: An analysis of 3359 twin pairs. Addiction 93:1375–1384, 1998.
Fagan P, Augustson E, Backinger CL et al. Quit attempts and intention to quit cigarette smoking among young adults in the United States. Am J Public Health 97:1412–1420, 2007.
Falk DE, Yi HY, Hiller-Sturmhöfel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res Health 29:162–171, 2006.
Fong T, Kalechstein A, Bernhard B et al. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav 89:298–303, 2008, Epub January 7, 2008.
Fuentes D, Tavares H, Artes R et al. Self-reported and neuropsychological measures of impulsivity in pathological gambling. J Int Neuropsychol Soc 12:907–912, 2006.
Gambino B, Fitzgerald R, Shaffer HJ et al. Perceived family history of problem gambling and scores on the SOGS. J Gambl Stud 9:169–184, 1993.
Gerstein D, Murphy S, Toce M et al. Gambling Impact and Behavior Study: Final Report to the National Gambling Impact Study Commission. Chicago: National Opinion Research Center (NORC), 1999.
Goudriaan AE, Oosterlaan J, de Beurs E et al. Neurocognitive functions in pathological gambling: A comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 101:534–547, 2006.
Grant JE, Donahue CJ, Odlaug BL et al. Imaginal desensitization plus motivational interviewing in the treatment of pathological gambling: A randomized controlled trial. Br J Psychiatry 195:226–267, 2009.
Grant JE, Kim SW. Demographic and clinical characteristics of 131 adult pathological gamblers. J Clin Psychiatry 62:957–962, 2001.
Grant JE, Kim SW. Parental bonding in pathological gambling disorder. Psychiatr Q 73:239–247, 2002.
Grant JE, Kim SW. Stop Me Because I Can't Stop Myself: Taking Control of Impulsive Behavior. New York: McGraw-Hill, 2003.
Grant JE, Kim SW. Quality of life in kleptomania and pathological gambling. Compr Psychiatry 46:34–37, 2005.
Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of pathological gambling urges. J Clin Psychiatry 69:783–789, 2008.
Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study. Biol Psychiatry 62:652–657, 2007.
Grant JE, Kim SW, Potenza MN et al. Paroxetine treatment of pathological gambling: A multi-centre randomized controlled trial. Int Clin Psychopharmacol 18:243–249, 2003.
Grant JE, Potenza MN. Impulse control disorders: Clinical characteristics and pharmacological management. Ann Clin Psychiatry 16:27–34, 2004.
Grant JE, Potenza MN. Tobacco use and pathological gambling. Ann Clin Psychiatry 17:237–241, 2005.
Grant JE, Potenza MN. Escitalopram treatment of pathological gambling with co-occurring anxiety: An open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol 21:203–209, 2006.
Grant JE, Potenza MN. Commentary: Illegal behavior and pathological gambling. J Am Acad Psychiatry Law 35:302–305, 2007.
Grant JE, Potenza MN, Hollander E et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163:303–312, 2006.
Hodgins DC, Currie S, el-Guebaly N. Motivational enhancement and self-help treatments for problem gambling. J Consult Clin Psychol 69:50–57, 2001.
Hodgins DC, Currie S, el-Guebaly N et al. Brief motivational treatment for problem gambling: a 24-month follow-up. Psychol Addict Behav 18:293–296, 2004.
Hodgins DC, Holub A. Treatment of problem gambling, in Research and Measurement Issues in Gambling Studies. Edited by Smith G, Hodgins DC, Williams RJ. Burlington, MA: Elsevier, 2007, pp. 371–397.
Hodgins DC, Peden N, Cassidy E. The association between comorbidity and outcome in pathological gambling: A prospective follow-up of recent quitters. J Gambl Stud 21:255–271, 2005.
Hollander E, DeCaria CM, Finkell JN et al. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 47:813–817, 2000.
Hollander E, Frenkel M, Decaria C et al. Treatment of pathological gambling with clomipramine (letter). Am J Psychiatry 149 (5): 710–711, 1992.
Hollander E, Pallanti S, Allen A et al. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162:137–145, 2005b.
Hollander E, Pallanti S, Baldini Rossi N et al. Imaging monetary reward in pathological gamblers. World J Biol Psychiatry 6:113–120, 2005a.
Ibáñez A, Blanco C, Moreryra P et al. Gender differences in pathological gambling. J Clin Psychiatry 64:295–301, 2003.
Ibáñez A, Blanco C, Sáiz-Ruiz J. Neurobiology and genetics of pathological gambling. Psychiatric Ann 32:181–185, 2002.
Jacobs J. Examination of sexually abused children. CMAJ 141:767, 1989.
Kalechstein AD, Fong T, Rosenthal RJ et al. Pathological gamblers demonstrate frontal lobe impairment consistent with that of methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci 19:298–303, 2007.
Kalivas PW, Peters J, Knackstedt L. Animal models and brain circuits in drug addiction. Mol Interv 6:339–344, 2006.
Kallick MD, Suits T, Deilman T et al. A survey of American gambling attitudes and behavior. Research report series, Survey Research Center, Institute for Social Research. Ann Arbor: University of Michigan Press, 1979.
Kertzman S, Lowengrub K, Aizer A et al. Stroop performance in pathological gamblers. Psychiatry Res 142:1–10, 2006.
Kim SW, Grant JE, Adson DE et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49:914–921, 2001.
Kim SW, Grant JE, Adson DE et al. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 63:501–507, 2002.
Ladd GT, Petry NM. Gender differences among pathological gamblers seeking treatment. Exp Clin Psychopharmacol 10:302–309, 2002.
Ladouceur R, Jacques C, Giroux I et al. Analysis of a casino's self-exclusion program. J Gambl Stud 16:453–460, 2000.
Ladouceur R, Sylvain C, Boutin C et al. Cognitive treatment of pathological gambling. J Nerv Ment Dis 189:774–780, 2001.
Ladouceur R, Sylvain C, Boutin C et al. Group therapy for pathological gamblers: A cognitive approach. Behav Res Ther 41:587–596, 2003.
Ledgerwood DM, Petry NM. Gambling and suicidality in treatment-seeking pathological gamblers. J Nerv Ment Dis 192:711–714, 2004.
Ledgerwood DM, Weinstock J, Morasco BJ et al. Clinical features and treatment prognosis of pathological gamblers with and without recent gambling-related illegal behavior. J Am Acad Psychiatry Law 35:294–301, 2007.
Lesieur HR. The compulsive gambler's spiral of options and involvement. Psychiatry 2:79–87, 1979.
Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): A new instrument for the identification of pathological gamblers. Am J Psychiatry 144:1184–1188, 1987.
Lesieur HR, Rosenthal RJ. Pathological gambling: A review of the literature (prepared for the American Psychiatric Association Task Force of DSM-IV Committee on Disorders of Impulse Control Not Elsewhere Classified). J Gambl Stud 7:5–39, 1991.
Linden RD, Pope HG, Jonas JM. Pathological gambling and major affective disorders: Preliminary findings. J Clin Psychiatry 47:201–203, 1986.
Marazziti D, Dell’Osso MC, Conversano C et al. Executive function abnormalities in pathological gamblers. Clin Pract Epidemiol Ment Health 4:7, 2008.
McConaghy N, Armstrong MS, Blaszczynski A et al. Controlled comparison of aversive therapy and imaginal desensitization in compulsive gambling. Br J Psychiatry 142:366–372, 1983.
McConaghy N, Armstrong MS, Blaszczynski A et al. Behavior completion versus stimulus control in compulsive gambling: Implications for behavioral assessment. Behav Modif 12:371–384, 1988.
McConaghy N, Blaszczynski A, Frankova A. Comparison of imaginal desensitization with other behavioural treatments of pathological gambling: A two- to nine-year follow-up. Br J Psychiatry 159:390–393, 1991.
McCormick RA, Russo AM, Ramirez LF et al. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 141:215–218, 1984.
McElroy SL, Nelson EB, Welge JA et al. Olanzapine in the treatment of pathological gambling: A negative randomized placebo-controlled trial. J Clin Psychiatry 69:433–440, 2008.
Melville CL, Davis CS, Matzenbacher DL et al. Node-link-mapping-enhanced group treatment for pathological gambling. Addict Behav 29:73–87, 2004.
Meyer G, Stadler MA. Criminal behavior associated with pathological gambling. J Gambl Stud 15:29–43, 1999.
Milton S, Crino R, Hunt C et al. The effect of compliance-improving interventions on the cognitive-behavioural treatment of pathological gambling. J Gambl Stud 18:207–229, 2002.
Morasco BJ, Petry NM. Gambling problems and health functioning in individuals receiving disability. Disabil Rehabil 28:619–623, 2006.
Morasco BJ, Vom Eigen KA, Petry NM. Severity of gambling is associated with physical and emotional health in urban primary care patients. Gen Hosp Psychiatry 28:94–100, 2006.
National Council on Problem Gambling and National Endowment for Financial Education. Personal Financial Strategies for the Loved Ones of Problem Gamblers. Greenwood Village, CO: National Endowment for Financial Education, 2000.
National Opinion Research Center. Gambling Impact and Behavior Study: Report to the National Gambling Impact Study Commission. Chicago: National Opinion Research Center at the University of Chicago, 1999. Available at http://www.norc.uchicago.edu/new/gamb-fin.htm.
National Research Council. Understanding Child Abuse Neglect. Washington, DC: National Academy Press, 1993.
Niederland WG. A contribution to the psychology of gambling. Psychoanal Forum 2:175–185, 1967.
Pallanti S, Bernardi S, Quercioli L. The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the assessment of multiple addictions in a high-school population: Prevalence and related disability. CNS Spectr 11:966–974, 2006.
Patterson JC 2nd, Holland J, Middleton R. Neuropsychological performance, impulsivity, and comorbid psychiatric illness in patients with pathological gambling undergoing treatment at the CORE Inpatient Treatment Center. South Med J 99:36–43, 2006.
Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol 110:482–487, 2001.
Petry NM. Pathological Gambling: Etiology, Comorbidity, and Treatment. Washington, DC: American Psychological Association, 2005.
Petry NM, Ammerman Y, Bohl J et al. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol 74:555–567, 2006.
Petry NM, Kiluk BD. Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J Nerv Ment Dis 190:462–469, 2002.
Petry NM, Oncken C. Cigarette smoking is associated with increased severity of gambling problems in treatment-seeking gamblers. Addiction 97:745–753, 2002.
Petry NM, Steinberg KL. Childhood maltreatment in male and female treatment-seeking pathological gamblers. Psychol Addict Behav 19:226–229, 2005.
Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 66:564–574, 2005.
Potenza MN, Leung HC, Blumberg HP et al. An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 160:1990–1994, 2003b.
Potenza MN, Steinberg MA, McLaughlin SD et al. Illegal behaviors in problem gambling: Analysis of data from a gambling helpline. J Am Acad Psychiatry Law 28:389–403, 2000.
Potenza MN, Steinberg MA, McLaughlin SD et al. Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry 158:1500–1505, 2001.
Potenza MN, Steinberg MA, McLaughlin SD et al. Characteristics of tobacco-smoking problem gamblers calling a gambling helpline. Am J Addict 13:471–493, 2004.
Potenza MN, Steinberg MA, Skudlarski P et al. Gambling urges in pathological gambling: A functional magnetic resonance imaging study. Arch Gen Psychiatry 60:828–836, 2003a.
Potenza MN, Xian H, Shah K et al. Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry 62:1015–1021, 2005.
Ramirez LF, McCormack RA, Russo AM et al. Patterns of substance abuse in pathological gamblers undergoing treatment. Addict Behav 8:425–428, 1983.
Regard M, Knoch D, Gütling E et al. Brain damage and addictive behavior: A neuropsychological and electroencephalogram investigation with pathologic gamblers. Cognit Behav Neurol 16:47–53, 2003.
Reuter J, Raedler T, Rose M et al. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8:147–148, 2005.
Rosenthal RJ. Pathological gambling. Psychiatr Ann 22:72–78, 1992.
Rosenthal RJ. Psychodynamic psychotherapy and the treatment of pathological gambling. Rev Bras Psiquiatr 30 Suppl 1: S41–50, 2008
Rosenthal RJ, Lorenz VC. The pathological gambler as criminal offender: Comments on evaluation and treatment. Psychiatr Clin North Am 15:647–660, 1992.
Roy A, Adinoff B, Roehrich L et al. Pathological gambling: A psychobiological study. Arch Gen Psychiatry 45:369–373, 1988.
Rugle L, Melamed L. Neuropsychological assessment of attention problems in pathological gamblers. J Nerv Ment Dis 181:107–112, 1993.
Sáiz-Ruiz J, Blanco C, Ibáñez A et al. Sertraline treatment of pathological gambling: A pilot study. J Clin Psychiatry 66:28–33, 2005.
Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: A research synthesis. Am J Pub Health 89:1369–1376, 1999.
Slutske WS. Natural recovery and treatment-seeking in pathological gambling: Results of two U.S. national surveys. Am J Psychiatry 163:297–302, 2006.
Slutske WS, Eisen S, True WR et al. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 57:666–673, 2000.
Slutske WS, Eisen S, Xian H et al. A twin study of the association between pathological gambling and antisocial personality disorder. J Abnorm Psychol 110:297–308, 2001.
Specker SM, Carlson GA, Christenson GA et al. Impulse control disorders and attention deficit disorder in pathological gamblers. Ann Clin Psychiatry 7:175–179, 1995.
Specker S, Carlson G, Edmonson K et al. Psychopathology in pathological gamblers seeking treatment. J Gambl Stud 12:67–81, 1996.
Stewart RM, Brown RI. An outcome study of Gamblers Anonymous. Br J Psychiatry 152:284–288, 1988.
Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: A controlled study. J Counsel Clin Psychol 65:727–732, 1997.
Taber JI, McCormick RA, Ramirez LF. The prevalence and impact of major life stressors among pathological gamblers. Int J Addict 22:71–79, 1987.
Vitaro F, Arseneault L, Tremblay RE. Dispositional predictors of problem gambling in male adolescents. Am J Psychiatry 154:1769–1770, 1997.
Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 20:484–492, 2007.
Welte J, Barnes G, Wieczorek W. Alcohol and gambling pathology among U.S. adults: Prevalence, demographic patterns and comorbidity. J Stud Alcohol 62:706–712, 2001.
Westphal JR, Rush J. Pathological gambling in Louisiana: An epidemiological perspective. J La State Med Soc 148:353–358, 1996.
Whitman-Raymond RG. Pathological gambling as a defense mechanism against loss. J Gambl Behav 4:99–109, 1988.
Wildman RW. Pathological gambling: Marital-familial factors, implications, and treatments. J Gambl Behav 5:293–301, 1989.
Winters KC, Rich T. A twin study of adult gambling behavior. J Gambl Stud 14:213–225, 1998.
World Health Organization. International Classification of Diseases, 1975 revision (ICD-9). Geneva: World Health Organization, 1977.
World Health Organization. International Classification of Mental Disorders: The ICD-10 Classification of Mental and Behavioural Disorders – Diagnostic Criteria for Research. Geneva: World Health Organization, 1992.
Wulfert E, Blanchard EB, Freidenberg BM. Retaining pathological gamblers in cognitive behavior therapy through motivational enhancement. Behav Modif 30:315–340, 2006.